2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 14:32 (2704 d 06:10 ago) – Posting: # 11336
Views: 35,464


» Followed by:
» If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.
» … provided that the group meets minimum requirements for a complete bioequivalence study.

According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Saturday 19:42 CET (Europe/Vienna)

If you can’t solve a problem, then there is an easier problem
you can solve: find it.    George Pólya

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz